Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433927
Status:
UNKNOWN
Last Update Posted:
2014-03-14
First Post:
2007-02-09
Brief Title:
5-FU Folinic Acid and Irinotecan FOLFIRI Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer CRC
Sponsor:
PD Dr med Volker Heinemann
Organization:
Ludwig-Maximilians - University of Munich
Organization Data
Organization:
Ludwig-Maximilians - University of Munich
Class:
OTHER
Study ID:
FIRE-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PD Dr med Volker Heinemann
Lead Sponsor Class:
OTHER
Responsible Party:
PD Dr med Volker Heinemann
Responsible Party Title:
Sponsor Delegated Person
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ludwig-Maximilians - University of Munich
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck KGaA Darmstadt Germany | INDUSTRY |